GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 100 | -29.6% | 0.00% | – |
| Q4 2020 | $6,000 | -99.9% | 142 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $5,090,000 | -13.9% | 92,316 | -1.4% | 0.07% | -19.3% |
| Q2 2020 | $5,910,000 | +6.6% | 93,622 | -13.7% | 0.08% | -15.3% |
| Q1 2020 | $5,542,000 | -36.3% | 108,467 | -0.9% | 0.10% | -15.5% |
| Q4 2019 | $8,701,000 | +24.1% | 109,466 | -24.3% | 0.12% | +17.2% |
| Q3 2019 | $7,012,000 | +29.6% | 144,514 | +40.5% | 0.10% | +20.7% |
| Q2 2019 | $5,411,000 | -22.4% | 102,872 | -21.9% | 0.08% | -26.8% |
| Q1 2019 | $6,973,000 | +11.2% | 131,732 | -13.8% | 0.11% | -9.7% |
| Q4 2018 | $6,273,000 | +19.2% | 152,806 | +10.3% | 0.12% | +45.9% |
| Q3 2018 | $5,263,000 | -16.4% | 138,487 | -0.6% | 0.08% | -17.5% |
| Q2 2018 | $6,297,000 | +9.7% | 139,312 | +17.3% | 0.10% | +6.2% |
| Q1 2018 | $5,738,000 | +0.1% | 118,809 | -18.5% | 0.10% | -1.0% |
| Q4 2017 | $5,734,000 | +79.0% | 145,717 | +41.2% | 0.10% | +84.9% |
| Q3 2017 | $3,204,000 | – | 103,198 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |